Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04608487
Title Axi-cel in CNS Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

B-cell lymphoma

central nervous system lymphoma

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Cyclophosphamide + Fludarabine

axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.